retatrutide triple hormone receptor agonist retatrutide Media Centre | EASD

Inhibition of incretins by DPP-4 inhibitors prolongs the half-life of incretins (GLP-1 & GIP) and is associated with increased insulin release & reduced glucagon release

Psychological & Physiological Dependence Patients may develop a psychological or physiological reliance on GLP-1 medications, complicating the discontinuation process

Mochis care model emphasizes safe titration, active monitoring, and clear guidance on pharmacy and coverage pathways to keep therapy sustainable

Peppermint oil capsules 0.2ml three times daily (enteric-coated to prevent heartburn)

Semaglutid fhrt bei einer HFpEF bei Adipositas nach einem Jahr zu einer strkeren Verringerung der mit der HI verbundenen Symptome und krperlichen Einschrnkungen sowie zu einem greren Gewichtsverlust als Placebo, STEP-HFpEF (18)

FDA American Diabetes Association